Commercial Serology Assays Predict Neutralization Activity Against SARS-CoV-2

Raymond T. Suhandynata, Melissa A. Hoffman, Deli Huang, Jenny T. Tran, Michael J. Kelner, Sharon L. Reed, Ronald W. McLawhon, James E. Voss, David Nemazee, Robert L. Fitzgerald
doi: https://doi.org/10.1101/2020.07.10.20150946

Article usage

Article usage: July 2020 to July 2025

AbstractFullPdf
Jul 20207800221
Aug 20202720108
Sep 2020163087
Oct 2020107055
Nov 202092053
Dec 202071037
Jan 202158346
Feb 202154018
Mar 202161342
Apr 202183143
May 202176026
Jun 202163231
Jul 202132237
Aug 202151639
Sep 202126023
Oct 202135037
Nov 202152231
Dec 202128016
Jan 20222067
Feb 202219210
Mar 202211312
Apr 202215026
May 202223313
Jun 20221415
Jul 20221222
Aug 20221422
Sep 202233115
Oct 202222011
Nov 20221016
Dec 20221058
Jan 20231654
Feb 20231365
Mar 202311011
Apr 20231929
May 2023814
Jun 20231048
Jul 2023304
Aug 2023201410
Sep 20231242
Oct 20231014
Nov 202327112
Dec 20231003
Jan 2024503
Feb 20241503
Mar 2024735
Apr 2024421
May 20241325
Jun 20241333
Jul 2024713
Aug 2024927
Sep 2024727
Oct 20241095
Nov 20248312
Dec 2024846
Jan 20251246
Feb 20255178
Mar 202529278
Apr 202517210
May 20252297
Jun 2025192310
Jul 2025111
Back to top
Posted July 11, 2020.
Download PDF

Supplementary Material

Data/Code
Email
Commercial Serology Assays Predict Neutralization Activity Against SARS-CoV-2
Raymond T. Suhandynata, Melissa A. Hoffman, Deli Huang, Jenny T. Tran, Michael J. Kelner, Sharon L. Reed, Ronald W. McLawhon, James E. Voss, David Nemazee, Robert L. Fitzgerald
medRxiv 2020.07.10.20150946; doi: https://doi.org/10.1101/2020.07.10.20150946
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area